By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2445 Faber Place
Suite 250
Palo Alto  California  94303  U.S.A.
Phone: 650-213-8444 Fax: 650-213-8383



Company News
CAPNIA, Inc. Added To Russell Microcap Index 6/29/2015 8:31:02 AM
CAPNIA, Inc. Announces Commencement Of Series B Warrant Exchange Offer 6/26/2015 7:01:18 AM
CAPNIA, Inc. To Present At 2015 Marcum MicroCap Conference 5/21/2015 4:21:21 PM
CAPNIA, Inc. Appoints Edward Ebbers As Chief Commercial Officer 4/13/2015 8:20:59 AM
CAPNIA, Inc. Awarded NIH Grant To Develop Sickle Cell Anemia Screening In Developing Countries 4/6/2015 6:59:43 AM
CAPNIA, Inc. Announces Receipt Of $3.6 Million From Series B Warrant Exercise And Issuance Of Series C Warrants 3/5/2015 7:33:32 AM
CAPNIA, Inc. Announces First U.S. Commercial Sales Of Cosense 2/17/2015 8:35:13 AM
CAPNIA, Inc. Applies For Orphan Drug Designation In The U.S. For The Treatment Of Trigeminal Neuralgia 1/8/2015 8:06:20 AM
CAPNIA, Inc. And Clinvest® Partner To Develop Cluster Headache Therapeutic 1/6/2015 9:32:26 AM
CAPNIA, Inc. To Present At OneMedForum 2015 1/5/2015 8:16:09 AM